Table 1.
Descriptive statistics of studies included.
| Number of studies | 43 | |
| Total number of participants | 27,703 | |
| Mean study participants (standard deviation) | 644 (sd: 1518) | |
| Median study participants | 102 | |
| Frequency |
Percentage |
|
| Year Published | (N = 43) | |
| 2018 | 1 | 2.3 % |
| 2019 | 3 | 7.0 % |
| 2020 | 10 | 23.3 % |
| 2021 | 8 | 18.6 % |
| 2022 | 10 | 23.3 % |
| 2023 | 7 | 16.3 % |
| 2024 | 4 | 9.3 % |
| Type of heart failure patients in the studies | ||
| HFrEF | 18 | 41.9 % |
| HFpEF | 3 | 7.0 % |
| Both | 22 | 51.2 % |
| Multi-country study | ||
| No | 35 | 81.4 % |
| Yes | 8 | 18.6 % |
| Pharmaceutical industry-funded studies | ||
| No | 18 | 41.9 % |
| Yes | 25 | 58.1 % |
| Race data reported | ||
| No | 18 | 41.9 % |
| Yes | 25 | 58.1 % |
| Females were at least a third of the participants. | ||
| No | 23 | 53.5 % |
| Yes | 20 | 46.5 % |